Neural Therapeutics Inc. Scientific Advisory Board Member Professor David Nutt presents fascinating insights into psychedelic medicine and its potential uses. The presentation focuses on what Professor Nutt describes as the utility of psychedelic compounds and their potential to transform the treatment of mental illness.
The presentation is introduced by Neural Therapeutics CEO and Director Ian Campbell.
Neural Therapeutics is a drug-discovery company focusing on plant-based active substances with the goal of delivering beneficial, over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments where no significant treatment is available today.